The promotor/promotors of Glenmark Pharmaceuticals Ltd are Glenn Saldanha, Cheryl Pinto, V S Mani, B E Saldanha, Rajesh Desai., Sona Saira Ramasastry, Dipankar Bhattacharjee, V R Iyer, Pradeep ...

Glenmark Pharma, an India-based drug manufacturer that has been the focal point of a spate of recalls in recent years, has issued another. This time, the product pull covers about 1.48 million ...

Glenmark Pharmaceuticals Ltd. (BSE: 532296) (NSE: GLENMARK) is a research–led, global pharmaceutical company, having a presence across Branded, Generics, and OTC segments; with a focus on ...

Feb 14 (Reuters) - India's Glenmark Pharmaceuticals (GLEN.NS), opens new tab reported third-quarter profit below estimates on Friday due to bleak U.S. demand for its long-term illness drugs.

Glenmark Therapeutics Inc., USA announced today the launch of its Polyethylene Glycol 3350, Powder for Solution, an over-the-counter laxative that will compete directly with Bayer’s MiraLAX.

Stock Market Today: Glenmark Pharmaceuticals share price gained more than 5% during intraday trades on Monday post Q3 Results that were declared after the market Hours. Glenmark Pharmaceuticals on ...

Glenmark Pharmaceuticals on Thursday said it has launched the generic version of Epinephrine injection multiple-dose vial in the US, which is eligible for 180 days of competitive generic therapy ...

New Jersey-based Glenmark Pharmaceuticals Inc, USA is recalling the made-in-India product in strengths ranging from 10 mg to 100 mg, USFDA stated.